Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yale SEVEN: B-DEX-MPA vs B-LB for Pain Control in Bilateral TKA
NCT05736549Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Feb 2023
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexamethasone sodium phosphate and methylprednisolone in postoperative pain (2 arms), sponsored by Yale University. Primary endpoints: Change in Postoperative Knee Pain at Day 2 and Postoperative opioid consumption up to 48 hours. Started Feb 2023; status: recruiting.
02
Drugs
dexamethasone sodium phosphatemethylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05736549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05736549.